”The FDA today asked the manufacturer of Rezulin (troglitazone) -- a drug used to treat type 2 diabetes mellitus -- to remove the product from the market. The drug's manufacturer, Parke-Davis/Warner-Lambert, has agreed to FDA's request. ... Severe liver toxicity has been known to occur with Rezulin since 1997.”
This instance of using a prescription drug as one part of a diabetes treatment makes me think of the warning Dr. Alex Duarte, PhD in Nutrition, issued more than two decades ago: “With prescription drugs, it’s not a question of IF there are side effects. All prescription drugs have side effects. The question is how many side effects are there, and how severe are those side effects?”
No comments:
Post a Comment